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Abstract
Genome scans using dense single-nucleotide polymorphism (SNP) data have recently become a
reality. It is thought that the increase in information content for linkage analysis as a result of the
denser scans will help refine previously identified linkage regions and possibly identify new regions
not identifiable using the sparser, microsatellite scans. In the context of the dense SNP scans, it is
also possible to consider association strategies to provide even more information about potential
regions of interest. To circumvent the multiple-testing issues inherent in association analysis, we
use a recently developed strategy, implemented in PBAT, which screens the data to identify the
optimal SNPs for testing, without biasing the nominal significance level. We compare the results
from the PBAT analysis to that of quantitative linkage analysis on chromosome 4 using the
Collaborative Study on the Genetics of Alcoholism data, as released through Genetic Analysis
Workshop 14.
Background
The rapid advance of genotyping technology has resulted
in a wealth of new, high-quality data that may hold prom-
ise for the further elucidation of the genetic determinants
underlying complex disease. The ultimate utility of such
rich data may be limited in scope by existing methods of
linkage and association analysis. For example, it is some-
what unclear as to whether increasingly dense single-
nucleotide polymorphism (SNP) genome scans will pro-
vide the necessary boost in power and/or information to
uncover genes of modest effect size. Further, association
methods will be subjected to extreme multiple compari-
son issues, as the number of statistical tests balloon with
the vast number of available SNPs. To address the issue of
multiple comparisons, recently developed screening tools
implemented in PBAT [1] have the potential to be a pow-
erful and unbiased strategy for genome-wide association
of family studies [2]. Briefly, the PBAT screening strategy
uses the information from uninformative families (infor-
mation otherwise discarded in a standard family-based
association setting) to screen and select the most optimal
markers for subsequent testing without biasing the nomi-
nal significance level. In this paper, we explore the utility
of the PBAT screening method in comparison with quan-
titative linkage analysis using the Collaborative Study on
the Genetics of Alcoholism (COGA) dataset, as released
through the Genetic Analysis Workshop 14 (GAW14). We
have the unique opportunity to use the same genetic
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markers for both linkage and association methods,
thereby allowing for a more direct and comprehensive
comparison of the two strategies.
Methods
Description of the dataset
The data provided for Problem 1 in the GAW14 dataset
(COGA Study) includes genotypes from the Affymetrix
GeneChip™ Human Mapping 10 K array (Affymetrix),
comprises 11,555 SNPs as well as quantitative trait infor-
mation for approximately 1,614 subjects from 143 fami-
lies of varying size and structure. Here, we focus on the
quantitative trait data from the Eyes Closed Resting elec-
troencephalogram experiment, and in particular the
measure that corresponds to the first component of a tri-
linear singular value decomposition of the beta2 band
and bipolar electrode data (ECB21). ECB21 was shown to
be approximately normally distributed with a mean of
14.53 (standard deviation = 5.5) and ranged from 4.43 to
36.06. There was no substantial skewness or kurtosis
found with the ECB21 trait. We restricted our analysis to
genotypes from the 786 Affymetrix SNPs on chromosome
4. We chose chromosome 4 because it has been proposed
to harbor a region of linkage to the ECB21 phenotype [3-
5].
Quantitative trait linkage analysis
We first performed a multipoint linkage analysis of the
ECB21 phenotype using the variance components
approach as implemented in MERLIN [6]. Allele frequen-
cies were generated using all genotyped individuals and
the marker map provided by Affymetrix was used for the
analysis. To assess whether linkage disequilibrium (LD)
structure has influence on the linkage signal, we used
HAPLOVIEW [7] to provide an indication of LD in the
sample. We removed markers that were found to be in
strong LD and re-analyzed the sample for linkage.
Quantitative trait association analysis
Each marker was tested for association with the ECB21
phenotype using the FBAT approach [8] as implemented
in PBAT. Association testing was done assuming an addi-
tive genetic model and theoretical variance estimate.
Through the computer software package PBAT, a new test-
ing strategy has been developed to address the multiple
testing issues for family-based association studies [9,10].
The PBAT strategy can be thought of as a screening tech-
nique, whereby the most powerful allelic-phenotype asso-
ciation combination is selected from an entire set of
allele-phenotype combinations available to the
researcher. Unlike standard methods, the PBAT strategy
does not bias the nominal significance level of the result-
ing univariate or multivariate FBAT statistic. PBAT accom-
plishes this by making use of the uninformative families.
For example, uninformative families could refer to
nuclear families where the two parents are homozygous at
a particular locus. The FBAT statistic does not use unin-
formative families because transmission from a
homozygous parent to its offspring is not random [8].
Thus, using the uninformative families to screen for the
optimal gene-phenotype combination does not bias the
significance level. Specific details about the method can
be found in Lange et al. [9,10]. Briefly, the method can be
broken down into six steps: 1) Select a subset of pheno-
types (or one phenotype) to be tested. 2) Generate a mul-
tivariate model that describes the selected phenotype(s) as
a function of the genotypes. 3) Replace the observed gen-
otypes for the informative families with their expected gen-
otypes conditional on parental genotypes. 4) Estimate the
effect-size parameters from the model in step 3. 5) Esti-
mate the power of the selected phenotype-genotype using
the conditional power approach [11]. 6) Use the standard
univariate FBAT approach on the phenotype-genotype
combination that has optimal power from step 5. For the
present analysis, we made use of PBAT's screening strategy
to select the five most powerful SNPs to be tested and
Bonferroni-adjusted the resulting FBAT p-values for five
tests. The rationale for selecting the five most powerful
SNPs was assessed via simulation studies conduced by
Van Steen et al. [2] that suggest that this is the optimal
strategy in the context of PBAT screening on this scale.
Linkage and association analysis on chromosome 4 Figure 1
Linkage and association analysis on chromosome 4. 
Graphical representation of analyzing the same markers for 
linkage and association analysis. The continuous line is a plot 
of the MERLIN LOD score p-value [plotted as -log(p-value)] 
by genetic location (in cM). The red symbols represent the p-
values [plotted as -log(p-value)] of the five SNPs that were 
found to be most powerful using the PBAT screening strat-
egy. The black dots represent the PBAT p-values for all other 
SNPs tested. The dotted horizontal reference line corre-
sponds to the 5% significance level for the five most powerful 
PBAT SNPs, Bonferroni-adjusted for five tests (or the 0.01 
significance level unadjusted).BMC Genetics 2005, 6:S96
Page 3 of 5
(page number not for citation purposes)
Results
Linkage analysis results
Variance component linkage analysis as implemented in
MERLIN resulted in a LOD score of 3.55 (p = 0.00003) for
ECB21 on chromosome 4. The marker corresponding to
that LOD score is TSC0149708, located at approximately
72 cM [physical location approximately 57.1 Mbp]. Figure
1 displays the results of the linkage analysis plotted as the
-log(p-value) using the MERLIN LOD score p-value. We
sequentially removed markers that were determined by
HAPLOVIEW to be in LD both in the linkage region and
outside the linkage region and found no difference in the
resulting LOD score (data not shown).
Association analysis results
Table 1 shows the results from the chromosome-wide
association analysis using PBAT. Presented in Table 1 are
the SNP name, minor allele, allele frequency, number of
uninformative families (out of 142), p-values, and MER-
LIN LOD scores for the ten most significant SNPs (lowest
p-values). The SNP showing the strongest association was
TSC0053776 (p  = 0.0011), located at around 100 cM
(physical location approximately 91.9 Mbp). After Bon-
ferroni-adjustment for multiple comparisons (number of
tests = 786), none of SNPs achieved statistical significance
at the 5% significance level. We also assessed significance
using the false discovery rate (FDR) method [12]. Consist-
ent with the Bonferroni-adjustment, one of the SNPs from
the FDR analysis reached statistical significance (q-value
for SNP TSC0053776 = 0.63). Further, the highest LOD
score among the 10 most significant SNPs was 2.18, for
SNP TSC0286605. This SNP also had the lowest PBAT p-
value among all SNPs that had LOD scores of greater than
2.0. Other PBAT p-values from SNPs with LOD scores over
2.0 were modest, with only three of them having p-values
of less than 0.05. Using PBAT's screening utility, we
focused our analysis on the five most powerful SNPs.
Table 2 shows the results of the analysis constrained to
these most powerful SNPs and found the top two SNPs to
be statistically significant after Bonferroni-adjustment for
five tests. The most powerful SNP (TSC0750487) had a p-
value of 0.0081. The location of the top two SNPs
(TSC0750487 and TSC0568024) are roughly the same in
genetic distance at approximately 35 cM, and are physi-
cally separated by only 1872 bp. None of the five most
powerful SNPs had LOD scores exceeding 1.0. In addition
to linkage analysis results, Figure 1 displays the PBAT
results as well. There are five red symbols that correspond
to the p-values for the five most powerful SNPs as identi-
fied through PBAT's screening utility (note: two symbols
overlap at around 36 cM). The horizontal dotted line
refers to the 5% significance level after Bonferroni-adjust-
ing for five comparisons. The black dots are the p-values
for all other SNPs tested using PBAT.
Discussion
Using Affymetrix SNPs from the COGA dataset, we identi-
fied a region that is linked (LOD = 3.55) to the ECB21
phenotype at approximately 70 cM. This region had been
previously identified in the COGA dataset by Reich et al.
[3] showing a maximum LOD score of 2.50 using affected
(alcoholism diagnosis) sibling pair methodology and
microsatellite markers. In addition, we were able to repli-
cate the approximate region of linkage as that found by
Porjesz et al. [5] using the same EEG measurement as used
for this analysis. Porjesz et al. reported a higher LOD score
(over 5.0) than we report here (3.55), however we did not
adjust our analysis for age and sex as was done by Porjesz
et al.
Using the screening, we also identified two SNPs that are
potentially associated with the ECB21 phenotype at
approximately 35 cM (p  = 0.0081 and 0.0085, respec-
tively). As expected, testing each of the 786 SNPs for asso-
ciation resulting in a severe multiple-testing issue, as none
of the SNPs across chromosome 4 was found to be statis-
tically significant using either a Bonferroni correction or
FDR methods. However, using PBAT's screening strategy
allowed us to reduce the number of tests. We chose to test
the top five most powerful SNPs as identified by PBAT,
and found two SNPs significantly associated with ECB21
at the 5% significance level (after Bonferroni-adjustment
for five tests). These two SNPs are physically very close to
each other (~2 kb), and when tested together using PBAT's
haplotype analysis function, the resulting 2 SNP haplo-
type maintained its significance and relative power (data
not shown).
Interestingly, the selected SNPs were not found to be
located directly in the linkage region, as the significant
SNPs are approximately 30–40 cM from the maximum
LOD score. Furthermore, the LOD scores corresponding
to the selected SNPs were 0. The discrepancy in these find-
ings may be explained in a number of ways, particularly
when one considers that the alternative hypothesis of the
FBAT strategy is the presence of linkage and association.
First, it is possible, albeit unlikely, that the association
approach was able to identify SNPs that are in LD with the
linkage region. Second, it has been suggested that associa-
tion analysis may be more powerful to detect genes of rel-
atively smaller effect sizes [13]. Therefore, it is conceivable
that the association strategy identified a novel region that
was not detectable by linkage analysis. Third, the associa-
tion could be completely due to chance, resulting in a
false positive for that region. It is also interesting that
PBAT did not find SNPs that were statistically significant in
the linkage region. However, given the alternative hypoth-
esis using the FBAT approach (presence of linkage and
association) it is possible that the SNPs (in relatively low
LD) displaying linkage are not associated with the under-BMC Genetics 2005, 6:S96
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lying causal locus. It should also be noted that the linkage
analysis conducted in the present study was not optimally
performed and therefore, we did not maximize the link-
age signal. However, the intent of the present study was to
compare the two strategies by highlighting key similarities
and differences, and not necessarily providing evidence in
support of one strategy over the other. Furthermore, we
propose that collectively, both strategies may prove useful
in high-density genome-wide scans.
Conclusion
We compared the similarities and differences between
linkage analysis and PBAT's approach to association anal-
ysis, using the same quantitative trait and using the same
marker set. In this brief exploration, we did not find that
linkage and association necessarily provided concordant
results. Nonetheless, in the context of the high-density
SNP scans, we feel that utilizing new strategies for associ-
ation testing may provide additional information not oth-
erwise discovered using linkage analysis alone.
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Table 1: Ten SNPs on chromosome 4 with the smallest p-values. The ten SNPs that had the smallest p-values (unadjusted) associated 
with ECB21 on chromosome 4 as estimated by PBAT. Corresponding MERLIN LOD scores are also shown.
SNP Allele Allele frequency No. of uninformative 
families
p-value (PBAT) LOD (MERLIN)
TSC0053776 1 0.17 117 0.0011 0.22
TSC0286605 1 0.38 105 0.0020 2.18
TSC0528073 1 0.29 114 0.0033 0.33
TSC0750487 2 0.33 110 0.0081 0.00
TSC0568024 1 0.33 111 0.0085 0.00
TSC0358705 1 0.25 117 0.0087 0.31
TSC0047225 1 0.37 95 0.0132 0.21
TSC0060984 1 0.30 120 0.0148 0.14
TSC1398038 1 0.24 115 0.0149 0.01
TSC0052464 2 0.46 107 0.0154 0.00
Table 2: Five most powerful SNPs on Chromosome 4. The five SNPs with the highest estimated power by PBAT screening on 
chromosome 4, and their corresponding p-values. Corresponding MERLIN LOD scores are also reported.
SNP Allele Allele Frequency No. of 
Uninformative 
Families
Power p-value (PBAT) LOD (MERLIN)
TSC0750487 2 0.33 110 0.96 0.0081 0.00
TSC0568024 1 0.33 111 0.95 0.0085 0.00
TSC0313521 2 0.11 117 0.94 0.1290 0.61
TSC0652507 1 0.34 115 0.94 0.9390 0.40
TSC0528071 1 0.30 115 0.93 0.0828 0.33Publish with BioMed Central    and   every 
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